Lisa Elefanti - Concepedia

Author

Lisa Elefanti

Istituto Oncologico Veneto ORCID

Also Known As

L. Elefanti, LISA ELEFANTI, Lisa Elefanti

Publications

543

Citations

H-Index

Concepts

All Affiliations

Istituto Oncologico Veneto University of Padua Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino University of Genoa

About

Lisa Elefanti is an author at Istituto Oncologico Veneto specializing in medicine, cancer research, and bioinformatics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	73
2	Engineering	2	2	34
3	Biomolecular Engineering	1	1	16
4	Biostatistics	1	1	16
5	Cell Biology	1	1	18

Lisa Elefanti

Publications

216

Citations

H-Index

Page 1

	Year	Citations
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup William Bruno, Lorenza Pastorino, Paola Ghiorzo, Journal of the American Academy of Dermatology Genetic AssessmentMedicineMelanomaGenetic EpidemiologyPathology	2016	39
<i>BRAF</i> Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors Camilla Stagni, Carolina Zamuner, Lisa Elefanti, Molecular Cancer Therapeutics	2018	34
The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI) Lisa Elefanti, Carolina Zamuner, Paolo Del Fiore, International Journal of Molecular Sciences	2021	21
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients Paola Del Bianco, Camilla Stagni, Silvia Giunco, Cancers	2020	19
<i>CDKN2A</i>Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment Maria Chiara Scaini, Giovanni Minervini, Lisa Elefanti, Human Mutation EngineeringMolecular BiologyP16ink4a VusSplicing VariantTumor Biology	2014	18
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup William Bruno, Bruna Dalmasso, Monica Barile, ESMO Open	2022	18
Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI Marco Carraro, Giovanni Minervini, Manuel Giollo, Human Mutation Unknown SignificanceEngineeringCagi P16ink4a ChallengePathologyEmpirical Energy Function	2017	16
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance Maria Chiara Scaini, Cristina Catoni, Cristina Poggiana, npj Precision Oncology	2024	16
Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations Valeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, Endocrine Pathology	2019	12
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients Cristina Pellegrini, Sara Raimondi, Lucia Di Nardo, Journal of the European Academy of Dermatology and Venereology	2021	12

Page 1